Are Quaternary Ammonium Compounds, the Workhorse Disinfectants, Effective against Severe Acute Respiratory Syndrome-Coronavirus-2?

A novel virus named Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) emerged from Wuhan, China in late 2019. Since then, the virus has quickly spread worldwide, leading the World Health Organization to declare it as a pandemic; by the end of April 2020, the number of cases exceeded 3 mil...

Full description

Saved in:
Bibliographic Details
Published inACS infectious diseases Vol. 6; no. 7; pp. 1553 - 1557
Main Authors Schrank, Cassandra L, Minbiole, Kevin P. C, Wuest, William M
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 10.07.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A novel virus named Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) emerged from Wuhan, China in late 2019. Since then, the virus has quickly spread worldwide, leading the World Health Organization to declare it as a pandemic; by the end of April 2020, the number of cases exceeded 3 million. Due to the high infectivity rate, SARS-CoV-2 is difficult to contain, making disinfectant protocols vital, especially for essential, highly trafficked areas such as hospitals, grocery stores, and delivery centers. According to the Centers for Disease Control and Prevention, best practices to slow the spread rely on good hand hygiene, including proper handwashing practices as well as the use of alcohol-based hand sanitizers. However, they provide warning against sanitizing products containing benzalkonium chloride (BAC), which has sparked concern in both the scientific community as well as the general public as BAC, a common quaternary ammonium compound (QAC), is ubiquitous in soaps and cleaning wipes as well as hospital sanitation kits. This viewpoint aims to highlight the outdated and incongruous data in the evaluation of BAC against the family of known coronaviruses and points to the need for further evaluation of the efficacy of QACs against coronaviruses.
AbstractList A novel virus named Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) emerged from Wuhan, China in late 2019. Since then, the virus has quickly spread worldwide, leading the World Health Organization to declare it as a pandemic; by the end of April 2020, the number of cases exceeded 3 million. Due to the high infectivity rate, SARS-CoV-2 is difficult to contain, making disinfectant protocols vital, especially for essential, highly trafficked areas such as hospitals, grocery stores, and delivery centers. According to the Centers for Disease Control and Prevention, best practices to slow the spread rely on good hand hygiene, including proper handwashing practices as well as the use of alcohol-based hand sanitizers. However, they provide warning against sanitizing products containing benzalkonium chloride (BAC), which has sparked concern in both the scientific community as well as the general public as BAC, a common quaternary ammonium compound (QAC), is ubiquitous in soaps and cleaning wipes as well as hospital sanitation kits. This viewpoint aims to highlight the outdated and incongruous data in the evaluation of BAC against the family of known coronaviruses and points to the need for further evaluation of the efficacy of QACs against coronaviruses.
A novel virus named SARS-CoV-2 emerged from Wuhan, China in late 2019. Since then, the virus has quickly spread worldwide, leading the WHO to declare it as a pandemic; by the end of April 2020, the number of cases exceeded 3 million. Due to the high infectivity rate, SARS-CoV-2 is difficult to contain, making disinfectant protocols vital, especially for essential, highly trafficked areas such as hospitals, grocery stores, and delivery centers. According to the CDC, best practices to slow the spread rely on good hand hygiene, including proper handwashing practices as well as the use of alcohol-based hand sanitizers (ABHS). However, they provide warning against sanitizing products containing benzalkonium chloride (BAC), which has sparked fear in both the scientific community as well as the general public as BAC, a common quaternary ammonium compound (QAC), is ubiquitous in soaps and cleaning wipes, as well as hospital sanitation kits. This viewpoint aims to highlight the outdated and incongruous data in the evaluation of BAC against the family of known coronaviruses, as well as points to the need for further evaluation of the efficacy of QACs against coronaviruses.
A novel virus named Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) emerged from Wuhan, China in late 2019. Since then, the virus has quickly spread worldwide, leading the World Health Organization to declare it as a pandemic; by the end of April 2020, the number of cases exceeded 3 million. Due to the high infectivity rate, SARS-CoV-2 is difficult to contain, making disinfectant protocols vital, especially for essential, highly trafficked areas such as hospitals, grocery stores, and delivery centers. According to the Centers for Disease Control and Prevention, best practices to slow the spread rely on good hand hygiene, including proper handwashing practices as well as the use of alcohol-based hand sanitizers. However, they provide warning against sanitizing products containing benzalkonium chloride (BAC), which has sparked concern in both the scientific community as well as the general public as BAC, a common quaternary ammonium compound (QAC), is ubiquitous in soaps and cleaning wipes as well as hospital sanitation kits. This viewpoint aims to highlight the outdated and incongruous data in the evaluation of BAC against the family of known coronaviruses and points to the need for further evaluation of the efficacy of QACs against coronaviruses.A novel virus named Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) emerged from Wuhan, China in late 2019. Since then, the virus has quickly spread worldwide, leading the World Health Organization to declare it as a pandemic; by the end of April 2020, the number of cases exceeded 3 million. Due to the high infectivity rate, SARS-CoV-2 is difficult to contain, making disinfectant protocols vital, especially for essential, highly trafficked areas such as hospitals, grocery stores, and delivery centers. According to the Centers for Disease Control and Prevention, best practices to slow the spread rely on good hand hygiene, including proper handwashing practices as well as the use of alcohol-based hand sanitizers. However, they provide warning against sanitizing products containing benzalkonium chloride (BAC), which has sparked concern in both the scientific community as well as the general public as BAC, a common quaternary ammonium compound (QAC), is ubiquitous in soaps and cleaning wipes as well as hospital sanitation kits. This viewpoint aims to highlight the outdated and incongruous data in the evaluation of BAC against the family of known coronaviruses and points to the need for further evaluation of the efficacy of QACs against coronaviruses.
Author Wuest, William M
Schrank, Cassandra L
Minbiole, Kevin P. C
AuthorAffiliation Department of Chemistry
Emory Antibiotic Resistance Center
Emory University School of Medicine
AuthorAffiliation_xml – name: Emory Antibiotic Resistance Center
– name: Emory University School of Medicine
– name: Department of Chemistry
– name: Department of Chemistry Emory University Atlanta, GA, 30322 USA
– name: Emory Antibiotic Resistance Center, Emory University School of Medicine Atlanta, GA, 30322 USA
– name: Department of Chemistry Villanova University Villanova, PA, 19085 USA
Author_xml – sequence: 1
  givenname: Cassandra L
  surname: Schrank
  fullname: Schrank, Cassandra L
  organization: Department of Chemistry
– sequence: 2
  givenname: Kevin P. C
  surname: Minbiole
  fullname: Minbiole, Kevin P. C
  email: kevin.minbiole@villanova.edu
  organization: Department of Chemistry
– sequence: 3
  givenname: William M
  orcidid: 0000-0002-5198-7744
  surname: Wuest
  fullname: Wuest, William M
  email: wwuest@emory.edu
  organization: Emory University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32412231$$D View this record in MEDLINE/PubMed
BookMark eNp9UUtPGzEQtipQgZRfUKnaYw9d8Pqx65xQlNIWCQm1tOrRmnhniemuHWxvJK795ThKQGkPnGak76WZ74QcOO-QkPcVPasoq87BROs6NK2NZ9RQymr5hhwz3vBSMdYc7O1H5DTGe0ppxZUUQr4lR5yJijFeHZO_s4DF9xESBgfhsZgNg3d2HIq5H1Z-dG38VKQlFr99-LP0IWLx2W6TE7iUwctus9s1FnAH1sVU3OIas-nMjAmLHxhXNkDy2fv20bXBD1jOffAO1jaMsWQX78hhB33E092ckF9fLn_Ov5XXN1-v5rPrEqSgqRSCMpQSoVEIyHirpo2ogTcLkAoUNhKUqmplsDWtqpRQtK1FU3ct1gsmKZ-Qi63valwMmYQuBej1KtghX649WP0v4uxS3_m1rqioxTS_c0I-7hyCfxgxJj3YaLDvwaEfo2aCCiqpECJTP-yHvaQ8fz4TpluCCT7GgJ02NkGyfpNt-xyqN0XrvaL1ruis5f9pn-1fV51vVRnU937MhffxVcUTTlvDLg
CitedBy_id crossref_primary_10_1134_S2635167621040170
crossref_primary_10_1016_j_chemosphere_2023_139460
crossref_primary_10_3390_biology11020209
crossref_primary_10_1021_acsnano_1c07888
crossref_primary_10_3390_applbiosci1030018
crossref_primary_10_1016_j_cmi_2021_07_029
crossref_primary_10_3390_molecules26195759
crossref_primary_10_1016_j_infpip_2023_100293
crossref_primary_10_1016_j_resconrec_2020_105156
crossref_primary_10_3390_jfb14070349
crossref_primary_10_1002_cmdc_202000612
crossref_primary_10_1002_smsc_202300052
crossref_primary_10_1016_j_clindermatol_2021_01_015
crossref_primary_10_3390_toxics11080687
crossref_primary_10_1002_anie_202412674
crossref_primary_10_13005_ojc_400607
crossref_primary_10_1016_j_molstruc_2022_132389
crossref_primary_10_1016_j_envint_2023_108021
crossref_primary_10_1111_jam_15437
crossref_primary_10_1016_j_jcis_2024_02_088
crossref_primary_10_1155_2022_7411957
crossref_primary_10_1371_journal_pone_0277881
crossref_primary_10_1016_j_aca_2021_338626
crossref_primary_10_1002_ardp_202300424
crossref_primary_10_1002_ppap_202000215
crossref_primary_10_1021_acs_jpcb_3c05531
crossref_primary_10_1002_app_55955
crossref_primary_10_2478_afpuc_2020_0017
crossref_primary_10_3390_ijms22136793
crossref_primary_10_4265_bio_27_223
crossref_primary_10_1021_acs_inorgchem_2c00600
crossref_primary_10_3390_biom14080957
crossref_primary_10_3390_ijms22179518
crossref_primary_10_1016_j_algal_2022_102796
crossref_primary_10_1021_acsabm_2c00901
crossref_primary_10_2166_wst_2023_076
crossref_primary_10_1016_j_ejps_2020_105559
crossref_primary_10_1021_acs_estlett_0c00437
crossref_primary_10_1016_j_jhazmat_2021_126210
crossref_primary_10_1007_s11274_020_02978_0
crossref_primary_10_1021_acsami_3c15125
crossref_primary_10_1155_ina_3951534
crossref_primary_10_3390_biology11091332
crossref_primary_10_1016_j_memsci_2022_121006
crossref_primary_10_1051_bioconf_20248601052
crossref_primary_10_1080_20477724_2020_1807177
crossref_primary_10_3390_applmicrobiol3020038
crossref_primary_10_1016_j_jhazmat_2022_130393
crossref_primary_10_3390_healthcare11060914
crossref_primary_10_1007_s12560_022_09517_0
crossref_primary_10_1002_ange_202412674
crossref_primary_10_1002_cmdc_202000604
crossref_primary_10_15616_BSL_2020_26_3_127
crossref_primary_10_3390_jcm10112303
crossref_primary_10_1039_D3VA00063J
crossref_primary_10_1038_s41598_021_82148_w
crossref_primary_10_1016_j_ijbiomac_2024_134865
crossref_primary_10_1016_j_colsurfa_2022_128944
crossref_primary_10_2147_IJN_S396669
crossref_primary_10_7717_peerj_12041
crossref_primary_10_1016_j_isci_2021_102304
crossref_primary_10_31857_S2308112023600114
crossref_primary_10_1016_j_cocis_2021_101479
crossref_primary_10_1016_j_bioorg_2024_107646
crossref_primary_10_1016_j_porgcoat_2024_108916
crossref_primary_10_3390_pharmaceutics14040805
crossref_primary_10_1016_j_jclepro_2022_134632
crossref_primary_10_3390_jpm11121243
crossref_primary_10_1016_j_jaap_2022_105447
crossref_primary_10_1016_j_eti_2022_102979
crossref_primary_10_1016_j_bioorg_2021_104938
crossref_primary_10_3390_polym13020207
crossref_primary_10_1016_j_cclet_2022_05_057
crossref_primary_10_1021_acsabm_2c00613
crossref_primary_10_1007_s11356_021_14429_w
crossref_primary_10_1016_j_jhin_2022_09_011
crossref_primary_10_1002_cmdc_202100284
crossref_primary_10_1016_j_reactfunctpolym_2025_106262
crossref_primary_10_1016_j_coesh_2021_100290
crossref_primary_10_3390_ijms23126645
crossref_primary_10_1016_j_infpip_2021_100191
crossref_primary_10_1134_S0965545X23600503
crossref_primary_10_3390_pharmaceutics14122791
crossref_primary_10_1016_j_bcp_2021_114467
crossref_primary_10_1016_j_jece_2022_107206
crossref_primary_10_1021_acs_chas_1c00026
crossref_primary_10_1016_j_ijbiomac_2023_125388
crossref_primary_10_1007_s13530_023_00173_w
crossref_primary_10_1186_s12985_023_02159_z
crossref_primary_10_15407_ubj94_03_081
crossref_primary_10_1016_j_heliyon_2023_e20067
crossref_primary_10_1002_kin_21537
crossref_primary_10_1128_mmbr_00205_22
crossref_primary_10_1016_j_scitotenv_2023_164764
crossref_primary_10_3390_ijms23105335
crossref_primary_10_1007_s13762_022_04326_1
crossref_primary_10_1016_j_intimp_2020_107220
crossref_primary_10_3390_jcm9082441
Cites_doi 10.1016/j.ajic.2009.03.012
10.1093/ajcp/aqaa029
10.1128/AEM.02633-14
10.1016/j.ijantimicag.2020.105924
10.1016/j.tetlet.2019.07.026
10.1128/AEM.07738-11
10.1016/j.jhin.2020.01.022
10.1002/jmv.25723
10.1056/NEJMc2004973
10.1001/jama.2020.3227
10.1021/acsinfecdis.5b00047
10.1007/b137625
10.1038/s41564-020-0695-z
10.1017/S0950268800030211
10.1016/j.jhin.2004.12.023
10.1111/j.1863-2378.2007.01079.x
10.1016/j.jevs.2013.12.010
10.1016/S0140-6736(20)30419-0
10.14744/ejmi.2020.38479
10.1021/acsinfecdis.5b00032
10.1016/S0195-6701(98)90077-9
10.1016/j.yrtph.2013.09.006
10.1016/S2666-5247(20)30003-3
10.1016/S0140-6736(20)30260-9
10.1016/S0140-6736(20)30462-1
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1021/acsinfecdis.0c00265
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2373-8227
EndPage 1557
ExternalDocumentID PMC10464937
32412231
10_1021_acsinfecdis_0c00265
g93443605
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ABMVS
ABUCX
ACGFS
ACS
AEESW
AFEFF
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
EBS
UI2
VF5
VG9
W1F
53G
AAYXX
ABBLG
ABJNI
ABLBI
ABQRX
ADHLV
BAANH
CITATION
CUPRZ
GGK
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-a540t-4402e55ea78eae23d89746a37ba58a8e75a88168cedcd818480d6476fde6b2503
IEDL.DBID ACS
ISSN 2373-8227
IngestDate Thu Aug 21 18:36:29 EDT 2025
Thu Jul 10 18:24:51 EDT 2025
Wed Feb 19 02:29:08 EST 2025
Tue Jul 01 01:32:32 EDT 2025
Thu Apr 24 23:01:52 EDT 2025
Thu Aug 27 13:41:52 EDT 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 7
Language English
License https://doi.org/10.15223/policy-017
https://doi.org/10.15223/policy-009
https://doi.org/10.15223/policy-001
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a540t-4402e55ea78eae23d89746a37ba58a8e75a88168cedcd818480d6476fde6b2503
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-5198-7744
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/10464937
PMID 32412231
PQID 2404050444
PQPubID 23479
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10464937
proquest_miscellaneous_2404050444
pubmed_primary_32412231
crossref_citationtrail_10_1021_acsinfecdis_0c00265
crossref_primary_10_1021_acsinfecdis_0c00265
acs_journals_10_1021_acsinfecdis_0c00265
ProviderPackageCode ACS
AEESW
AFEFF
VF5
VG9
ABMVS
ABUCX
AQSVZ
W1F
UI2
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-07-10
PublicationDateYYYYMMDD 2020-07-10
PublicationDate_xml – month: 07
  year: 2020
  text: 2020-07-10
  day: 10
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle ACS infectious diseases
PublicationTitleAlternate ACS Infect. Dis
PublicationYear 2020
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref6/cit6
ref3/cit3
ref27/cit27
ref18/cit18
ref11/cit11
ref25/cit25
ref16/cit16
Schmidt A. (ref30/cit30) 2005
Ansaldi F. (ref29/cit29) 2004; 45
ref23/cit23
ref14/cit14
ref8/cit8
ref5/cit5
ref31/cit31
ref2/cit2
ref28/cit28
ref20/cit20
ref17/cit17
ref10/cit10
ref26/cit26
ref19/cit19
ref21/cit21
ref12/cit12
ref15/cit15
ref22/cit22
ref13/cit13
Ceccarelli M. (ref9/cit9) 2020; 24
ref4/cit4
ref1/cit1
ref24/cit24
ref7/cit7
References_xml – ident: ref6/cit6
  doi: 10.1016/j.ajic.2009.03.012
– ident: ref2/cit2
  doi: 10.1093/ajcp/aqaa029
– ident: ref14/cit14
– ident: ref22/cit22
  doi: 10.1128/AEM.02633-14
– ident: ref10/cit10
  doi: 10.1016/j.ijantimicag.2020.105924
– ident: ref25/cit25
  doi: 10.1016/j.tetlet.2019.07.026
– volume: 24
  start-page: 2781
  year: 2020
  ident: ref9/cit9
  publication-title: Eur. Rev. Med. Pharmacol Sci.
– ident: ref24/cit24
  doi: 10.1128/AEM.07738-11
– ident: ref15/cit15
  doi: 10.1016/j.jhin.2020.01.022
– ident: ref4/cit4
– ident: ref13/cit13
  doi: 10.1002/jmv.25723
– ident: ref16/cit16
  doi: 10.1056/NEJMc2004973
– ident: ref17/cit17
  doi: 10.1001/jama.2020.3227
– ident: ref26/cit26
  doi: 10.1021/acsinfecdis.5b00047
– volume-title: Coronaviruses with Special Emphasis on First Insights Concerning SARS
  year: 2005
  ident: ref30/cit30
  doi: 10.1007/b137625
– ident: ref8/cit8
  doi: 10.1038/s41564-020-0695-z
– ident: ref20/cit20
  doi: 10.1017/S0950268800030211
– ident: ref31/cit31
  doi: 10.1016/j.jhin.2004.12.023
– ident: ref3/cit3
  doi: 10.1038/s41564-020-0695-z
– ident: ref28/cit28
  doi: 10.1111/j.1863-2378.2007.01079.x
– ident: ref21/cit21
  doi: 10.1016/j.jevs.2013.12.010
– ident: ref1/cit1
  doi: 10.1016/S0140-6736(20)30419-0
– ident: ref7/cit7
  doi: 10.14744/ejmi.2020.38479
– ident: ref27/cit27
  doi: 10.1021/acsinfecdis.5b00032
– ident: ref19/cit19
  doi: 10.1016/S0195-6701(98)90077-9
– ident: ref23/cit23
  doi: 10.1016/j.yrtph.2013.09.006
– ident: ref5/cit5
– ident: ref18/cit18
  doi: 10.1016/S2666-5247(20)30003-3
– volume: 45
  start-page: 5
  year: 2004
  ident: ref29/cit29
  publication-title: J. Prev Med. Hyg
– ident: ref11/cit11
  doi: 10.1016/S0140-6736(20)30260-9
– ident: ref12/cit12
  doi: 10.1016/S0140-6736(20)30462-1
SSID ssj0001385445
Score 2.4952593
SecondaryResourceType review_article
Snippet A novel virus named Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) emerged from Wuhan, China in late 2019. Since then, the virus has quickly...
A novel virus named SARS-CoV-2 emerged from Wuhan, China in late 2019. Since then, the virus has quickly spread worldwide, leading the WHO to declare it as a...
SourceID pubmedcentral
proquest
pubmed
crossref
acs
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1553
SubjectTerms Anti-Infective Agents, Local - pharmacology
Benzalkonium Compounds - pharmacology
Betacoronavirus - chemistry
Betacoronavirus - drug effects
Coronavirus Infections - prevention & control
Coronavirus Infections - virology
COVID-19
Disinfectants - pharmacology
Disinfection - methods
Hand Disinfection - methods
Humans
Membrane Lipids
Pandemics - prevention & control
Pneumonia, Viral - prevention & control
Pneumonia, Viral - virology
Sanitation - methods
SARS-CoV-2
Treatment Outcome
Virus Replication - drug effects
Title Are Quaternary Ammonium Compounds, the Workhorse Disinfectants, Effective against Severe Acute Respiratory Syndrome-Coronavirus-2?
URI http://dx.doi.org/10.1021/acsinfecdis.0c00265
https://www.ncbi.nlm.nih.gov/pubmed/32412231
https://www.proquest.com/docview/2404050444
https://pubmed.ncbi.nlm.nih.gov/PMC10464937
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELagSIhLy7vLS0biwKFe8nAS7wlFC1WFRCVYKvUWjZ3ZNgKyKA8keuwv70yS3e62qOo1fkSZzHi-8djfCPHOc77VnkWy7wkqPQmMgnmsFUZ2HpkQtXXdKd_D-OBIfzmOjtcuq1_J4Af-B3B1dy4pL-qx5zhmiO6Ke0FsEo610unsckslNEwt05WTS0JFri9Z8gz9fx72SK7e9EjXYObV05Jr7md_RxwuL_H0p05-jtvGjt3ZdU7H233ZQ7E9AFGZ9przSNzB8rG4_3VItT8R52mF8lsL3YZh9U-mrLBF-1vyCsK1mOo9SeBR8m776aKqUX4q-hdxXWJq7HmRaTGVcAIFoVA5Q7IblKlrG5TfL3P8cjbQJqgp8ynA36JqaxV8fCqO9j__mB6ooWCDAgJ-jdIUjGIUISQGAYMwNxStxBAmFiIDBpMIDNf5cCTMnJCCNl4e6ySe5xhbwmLhM7FVLkrcFdLNvZyeEMKIQfu5s5PEWQAbT7QDC-FIvCfxZYPB1VmXSw_8bE2m2SDTkQiW_zdzA_E519_4dfOgvdWgPz3vx83d3y4VJyP75KQLlLho64wQE2FiZuUbiee9Iq0mJDDrEzzzR8JsqNiqA3N_b7aUxWnHAc6peU3Q8sXt5fBSPAh4s4BZQb1XYqupWnxNiKqxbzo7ugC5miGS
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzV1Lb9QwEB6VIgEX3o_laSSQODRLHk7iPSC02lJt6UOCbaXeUtuZpRGQRXECKkd-C3-F_8U4j91uQRWXSlzj2HLssecb-8s3AM9c7SnuKqT1PUCHD3zhyGnEHQzVNBQBcqVrlu9uNN7nbw_CgxX42f0LQ50w1JKpL_EX6gLeS3pW05PSzPRdbUOHjkq5hcffKFAzrzbXaVaf-_7Gm73R2GlzCTiSMEnpcIqTMAxRxgIl-kEqCEhHMoiVDIUUGIdS2BQUGlOdkhPjwk0jHkfTFCNFMCGgdi_ARYI_vg3xhqPJ4iQnEFbRps5iFwcOedy4kzf6e7-tI9Rm2RH-gW5PkzRPeL2Na_BrPl412eVjvypVX38_JSX5vw_odbjawm42bNbJDVjB_CZc2mmJBbfgx7BA9q6S9fFoccyGdnlm1Wdm90ubecqsMYLKzN4tHM0Kg2w9az7MZmGmwkYFmlwHkx9kRpibTZB2CWRDXZXI3i8YDWzSikQ4I6seIb9mRWUc__Vt2D-XEbgDq_ksx3vA9NRN6QnhqUhyL9VqEGslpYoGXEslgx68oOlK2u3FJDVzwPeSE3OYtHPYA78zq0S3Mu8228insyutzSt9aVROzn79aWevCe1G9opJ5jirTEL4kCIAq0HYg7uN_c4bJOjuERj1eiCWLHv-glU6Xy7Js6Na8dwSETgB6fv_Pg5P4PJ4b2c72d7c3XoAV3x7TGL1UN2HsFoWFT4iLFmqx_VSZnB43qb-G8QRg4w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKkSou5Q3L00ggcWiWPJzHHhCKdlm1FCpgqdRbsJ1JGwHZKk5A5civ4a_wr5jJY9stqOLSA9ckthJ7xvON_eUbxh7b2lHCVoD-PQJLjNzIklkgLPBV5kceCKUblu9OsLkrXu35eyvsZ_8vDL6EwZ5Mc4hPXn2YZp3CgPMMrzcUpTQ3Q1tT-tDTKbfh6Bsma-b51gRn9onrTl9-GG9aXT0BSyIuqSyBuRL4PsgwAgmul0YIpgPphUr6kYwg9GVEZSg0pDrFQCYiOw1EGGQpBAqhgof9XmAX6aCQ0rx4PDvezfEiUrVpKtmFnoVRN-wljv7-3hQMtVkOhn8g3NNEzRORb3qZ_VqMWUN4-TSsKzXU30_JSf4Pg3qFrXfwm8etv1xlK1BcY2tvOoLBdfYjLoG_q2WzTVoe8ZjcNK-_cFo3qQKV2eAImTmdMRzMSwN8krcfRtWY8WarBo0hhMt9mSP25jPA1QJ4rOsK-PtjZgOfdWIR1phUJOTXvKyN5b64wXbPZQRustViXsBtxnVmp3gFcVUghZNqNQq1klIFI6Glkt6APcXpSrplxiQNg8B1khNzmHRzOGBub1qJ7uTeqerI57MbbSwaHbZqJ2c__qi32QRXJTpqkgXMa5MgTsRMgLQIB-xWa8OLDhHCOwhKnQGLlqx78QApni_fKfKDRvmcCAkCAfWdfx-Hh2zt7WSavN7a2b7LLrm0W0KyqPY9tlqVNdxHSFmpB403c_bxvC39NzqEhg8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Are+Quaternary+Ammonium+Compounds%2C+the+Workhorse+Disinfectants%2C+Effective+against+Severe+Acute+Respiratory+Syndrome-Coronavirus-2%3F&rft.jtitle=ACS+infectious+diseases&rft.au=Schrank%2C+Cassandra+L&rft.au=Minbiole%2C+Kevin+P+C&rft.au=Wuest%2C+William+M&rft.date=2020-07-10&rft.issn=2373-8227&rft.eissn=2373-8227&rft.volume=6&rft.issue=7&rft.spage=1553&rft_id=info:doi/10.1021%2Facsinfecdis.0c00265&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2373-8227&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2373-8227&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2373-8227&client=summon